Research
The Section has a wide and varied research portfolio that extends from basic bench-focused studies of disease pathogenesis and target gene validation to human-based studies of clinical issues such as cognitive impairment in the MICU. A unifying theme amongst the bench focused investigators is the desire to elucidate the cellular and molecular events involved in lung injury and repair. The result has been an intense focus on immunology and molecular biology and the development of scientific approaches at Yale that are now used through out the world. The investigators and their programs are highlighted below.
Cutting edge and innovative genetic-based approach to patient relevant research
Transformation of basic science discoveries into goal-oriented translational research
Clinical-based patient-oriented outcome research
Study of the role of immune cells in multiple advanced lung diseases
Investigations on the mechanisms of lung fibrosis and repair
Research on mechanisms of lung injury and inflammation
Focus on the molecular and cellular changes in the lung with aging
Study of the interaction between microbial pathogens and the host
Development of new therapeutics for lung diesases, critical care illness and sleep disorders